Cancer Research Institute (CRI) shared a post on LinkedIn:
“How could inherited cancer risks be used for effective personalized therapy?
A study from Yale School of Medicine and NYU Grossman School of Medicine researchers reveals new insights into the protective role of the BRCA2 gene, and offers leads into how an existing class of drugs used to treat cancer could be improved.
Discover.”